π₯π BizChicken ππ₯
Companies Similar to Longeveron Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CASI Pharmaceuticals, Inc.
EVOMELA
CASI Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes therapeutics and pharmaceutical products focusing on markets in China, the United States, and internationally. Major products include EVOMELA and a pipeline with several investigational products targeting various cancers.
About | About | Contact | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About
Symbol: CASI
Recent Price: $2.93
Industry: Biotechnology
CEO: Dr. Wei-Wu He Ph.D.
Sector: Healthcare
Employees: 176
Address: 9620 Medical Center Drive, Rockville, MD 20850
Phone: 240 864 2600
Last updated: 2024-12-31
Lixte Biotechnology Holdings, Inc.
LB-100 series and LB-200 series
Lixte Biotechnology Holdings, Inc. is a drug discovery company leveraging biomarker technology to develop enzyme-targeting drugs for cancer, vascular, metabolic, hereditary, and neurodegenerative diseases.
Symbol: LIXT
Recent Price: $2.00
Industry: Biotechnology
CEO: Mr. Bastiaan van der Baan M.Sc.
Sector: Healthcare
Employees: 3
Address: 680 East Colorado Boulevard, Pasadena, CA 91101
Phone: 631 830 7092
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Arcellx, Inc.
CART-dd BCMA
Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.
About | About | News | Contact | Contact | Culture | Culture | Culture | Culture | About | About | About | About | About | News
Symbol: ACLX
Recent Price: $78.35
Industry: Biotechnology
CEO: Mr. Rami Elghandour
Sector: Healthcare
Employees: 130
Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878
Phone: 240 327 0603
Last updated: 2024-12-31
180 Life Sciences Corp.
Therapeutics for chronic pain, inflammation, fibrosis, and inflammatory diseases
1180 Life Sciences Corp. is a clinical-stage biotechnology company focused on developing therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis, using platforms such as fibrosis and anti-TNF, synthetic CBD analogs, and a7n ACh R.
Symbol: ATNF
Recent Price: $2.98
Industry: Biotechnology
CEO: Mr. Lloyd Blair Jordan L.L.B., M.B.A.
Sector: Healthcare
Employees: 4
Address: Building 4, Palo Alto, CA 94306
Phone: 650 507 0669
Last updated: 2024-11-08
BioVie Inc.
BIV201, NE3107
Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.
Symbol: BIVI
Recent Price: $2.09
Industry: Biotechnology
CEO: Mr. Cuong Viet Do M.B.A.
Sector: Healthcare
Employees: 14
Address: 680 West Nye Lane, Carson City, NV 89703
Phone: 775 888 3162
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for Γ-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
CervoMed Inc.
neflamapimod
Cervo Med Inc. is a clinical-stage biotechnology company focused on developing and commercializing drug treatments for neurodegenerative diseases, including neflamapimod for conditions like dementia with Lewy bodies, Alzheimer's diseases, and brain stroke recovery.
Symbol: CRVO
Recent Price: $2.39
Industry: Biotechnology
CEO: Dr. John J. Alam M.D.
Sector: Healthcare
Employees: 8
Address: 20 Park Plaza, Boston, MA 02116
Phone: 617-744-4400
Last updated: 2024-12-31
Iovance Biotherapeutics, Inc.
lifileucel
Iovance Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing cancer immunotherapy products to utilize the immune system in eradicating cancer cells, with several ongoing phase 2 clinical studies.
Symbol: IOVA
Recent Price: $7.17
Industry: Biotechnology
CEO: Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Sector: Healthcare
Employees: 557
Address: 825 Industrial Road, San Carlos, CA 94070
Phone: 650 260 7120
Last updated: 2024-12-31
Legend Biotech Corporation
LCAR-B38M
Legend Biotech Corporation is a clinical-stage biopharmaceutical company focusing on the discovery and development of novel cell therapies for oncology and other indications globally.
About | Our Story | Leadership | About | About | Contact | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | About | About
Symbol: LEGN
Recent Price: $32.77
Industry: Biotechnology
CEO: Dr. Ying Huang Ph.D.
Sector: Healthcare
Employees: 2200
Address: 2101 Cottontail Lane, Somerset, NJ 08873
Phone: 732 317 5050
Leadership
- Ying Huang, Ph.D., CHIEF EXECUTIVE OFFICER
- Guowei Fang, Ph.D., CHIEF SCIENTIFIC OFFICER AND HEAD OF BUSINESS DEVELOPMENT
- Lori Macomber, CHIEF FINANCIAL OFFICER
- Mythili Koneru, M.D., Ph.D., CHIEF MEDICAL OFFICER
- Jim Pepin, GENERAL COUNSEL
- Steve Gavel, SENIOR VICE PRESIDENT, COMMERCIAL DEVELOPMENT, US & EUROPE
- Yuhong Qiu, Ph.D., SENIOR VICE PRESIDENT, GLOBAL REGULATORY AFFAIRS
- Birk VanderweeΓ«n, SENIOR VICE PRESIDENT, GLOBAL MANUFACTURING & SUPPLY
- Alan Kick, SENIOR VICE PRESIDENT, GLOBAL QUALITY
- Doug Wallace, VICE PRESIDENT, GLOBAL OPERATIONS
- Elaine Qian, VICE PRESIDENT, GLOBAL HEAD OF HUMAN RESOURCES
- Tim Roberts, Global Compliance Officer
- Simon Wu, Senior Vice President, General Manager, Greater China
- Frank Zhang, EMBA, Ph.D., CHAIRMAN OF THE BOARD, LEGEND BIOTECH
- Sally Wang, M.S., PRESIDENT, GENSCRIPT
- Zhu Li, Ph.D., CHIEF STRATEGY OFFICER, GENSCRIPT
- Corazon (Corsee) Dating Sanders, Ph.D., CO-CHAIR OF THE BOARD OF ADVISORS, FRED HUTCH CANCER CENTER
- Darren Ji, M.D., Ph.D. and MBA, CHAIRMAN AND CEO, ELPISCIENCE BIOPHARMACEUTICALS
- Philip Yau, CHIEF FINANCIAL OFFICER. C&J CLARK
- Patrick Casey, Ph.D., SENIOR VICE DEAN OF RESEARCH, DUKE-NUS MEDICAL SCHOOL SINGAPORE AND A JAMES B. DUKE PROFESSOR OF PHARMACOLOGY AND CANCER BIOLOGY, DUKE UNIVERSITY
- Tomas J. Heyman, CEO, INTERLAKEN THERAPEUTICS
- Li Mao, M.D., CHIEF MEDICAL OFFICER, SCICLONE PHARMACEUTICALS
- Peter Salovey, Ph.D., Chris Argyris Professor of Psychology; Professor of Management, Epidemiology & Public Health, and Sociology; and President Emeritus of Yale University
- Michel Vounatsos, FORMER CEO OF BIOGEN INC.
- John Maraganore, Ph.D., FORMER CEO OF ALNYLAM PHARMACEUTICALS
Last updated: 2024-12-31
Longeveron Inc.
LOMECEL-B
Longeveron Inc. is a biotechnology company that develops cellular therapies for aging-related and life-threatening conditions. Its leading product, LOMECEL-B, undergoes clinical trials for various serious health indications.
About | History | Leadership | Directors | About | Contact | Careers | Vision/Values | Careers | Careers | About | ESG | About | About
Symbol: LGVN
Recent Price: $1.77
Industry: Biotechnology
CEO: Mr. Mohamed Wa'el Ahmed Hashad M.B.A.
Sector: Healthcare
Employees: 23
Address: 1951 NW 7th Avenue, Miami, FL 33136
Phone: 305 909 0840
Leadership
- Wa'el Hashad, Chief Executive Officer
- K. Chris Min, MD, Ph.D., Acting Chief Medical Officer
- Joshua M. Hare, MD, FACC, FAHA, Chairman, Chief Science Officer
- Lisa Locklear, Chief Financial Officer
- Nataliya Agafonova, MD, Chief Medical Officer
- James Clavijo, Acting Chief Financial Officer
- Paul Lehr, JD, General Counsel and Secretary
- Lisa McClain-Moss, Vice President, Manufacturing
- Jerome Bailey, Vice President of Business Operations
- Elly Ryu, Vice President & Corporate Controller
- Brian Rash, Vice President of Research & Discovery
- Mike Mannarino, Vice President and Corporate Controller
- Tavara Andrews, Vice President & Corporate Controller
- Anthony Oliva, Ph.D., Senior Scientist
- Dan Gincel, Ph.D., Senior VP, Strategic Collaborations & Scientific Affairs
- Dr. Kevin Ramdas, Director, Clinical Operations
- Kwan-Hong Chris Min, Acting Chief Medical Officer
- Donald M. Soffer, Board of Directors
- Khoso Baluch, Independent Director
- Jeffrey Pfeffer, Board of Directors
- Richard Kender, Board of Directors
- Neil E. Hare, JD, Board of Directors
- Rock Soffer, Board of Directors
- Douglas Losordo, MD, Board of Directors
- Erin Borger, Board of Directors
- Cathy Ross, Board of Directors
- Ursula Ungaro, Board of Directors
- Neha Motwani, Board of Directors
- Roger Hajjar, MD, Board of Directors
- Todd Girolamo, JD, MBA, Board of Directors
Last updated: 2024-12-31
Vericel Corporation
MACI, Epicel, NexoBrid
Vericel Corporation is a commercial-stage biopharmaceutical company focusing on the development, manufacture, and distribution of cellular therapies for sports medicine and burn care in the United States. Their products include MACI for cartilage repair and Epicel for burn treatment.
About | About | Contact | Careers | Careers | About | About | About | About | Careers | About | About | About | About | About | About | About | About | About | About | Contact
Symbol: VCEL
Recent Price: $55.30
Industry: Biotechnology
CEO: Mr. Dominick C. Colangelo Esq.
Sector: Healthcare
Employees: 314
Address: 64 Sidney Street, Cambridge, MA 02139
Phone: 617 588 5555
Last updated: 2024-12-31
Creative Medical Technology Holdings, Inc.
Imm Celz
Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.
Symbol: CELZ
Recent Price: $2.34
Industry: Biotechnology
CEO: Mr. Timothy Warbington
Sector: Healthcare
Employees: 4
Address: 211 East Osborn Road, Phoenix, AZ 85012
Phone: 480 399 2822
Last updated: 2024-12-31
Exelixis, Inc.
CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.
Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers
Symbol: EXEL
Recent Price: $33.70
Industry: Biotechnology
CEO: Dr. Michael M. Morrissey Ph.D.
Sector: Healthcare
Employees: 1310
Address: 1851 Harbor Bay Parkway, Alameda, CA 94502
Phone: 650 837 7000
Last updated: 2024-12-31